<?xml version='1.0' encoding='utf-8'?>
<document id="31384926"><sentence text="Assessing Major Bleeding Risk in Atrial Fibrillation Patients Concurrently Taking Non-Vitamin K Antagonist Oral Anticoagulants and Antiepileptic Drugs." /><sentence text="This study compared the risk of major bleeding between atrial fibrillation (AF) patients who took non-vitamin-K antagonist oral anticoagulants (NOACs) and antiepileptic drugs (AEDs) concurrently and those who took only NOACs" /><sentence text="" /><sentence text="We performed a retrospective cohort study using Taiwan National Health Insurance database and included AF patients who received NOAC prescriptions from June 1, 2012, to December 31, 2017" /><sentence text=" The major bleeding risks of person-quarters exposed to NOAC and 11 concurrent AEDs (carbamazepine, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, phenobarbital, phenytoin, pregabalin, topiramate, valproic acid, and zonisamide) were compared with person-quarters exposed to NOAC alone"><entity charOffset="85-98" id="DDI-PubMed.31384926.s5.e0" text="carbamazepine" /><entity charOffset="100-110" id="DDI-PubMed.31384926.s5.e1" text="gabapentin" /><entity charOffset="112-123" id="DDI-PubMed.31384926.s5.e2" text="lamotrigine" /><entity charOffset="125-138" id="DDI-PubMed.31384926.s5.e3" text="levetiracetam" /><entity charOffset="140-153" id="DDI-PubMed.31384926.s5.e4" text="oxcarbazepine" /><entity charOffset="155-168" id="DDI-PubMed.31384926.s5.e5" text="phenobarbital" /><entity charOffset="170-179" id="DDI-PubMed.31384926.s5.e6" text="phenytoin" /><entity charOffset="181-191" id="DDI-PubMed.31384926.s5.e7" text="pregabalin" /><entity charOffset="193-203" id="DDI-PubMed.31384926.s5.e8" text="topiramate" /><entity charOffset="205-218" id="DDI-PubMed.31384926.s5.e9" text="valproic acid" /><entity charOffset="224-234" id="DDI-PubMed.31384926.s5.e10" text="zonisamide" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e5" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e0" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e5" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e1" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e5" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e2" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e5" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e3" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e4" e2="DDI-PubMed.31384926.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e4" e2="DDI-PubMed.31384926.s5.e5" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e4" e2="DDI-PubMed.31384926.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e4" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e4" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e4" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e4" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e5" e2="DDI-PubMed.31384926.s5.e5" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e5" e2="DDI-PubMed.31384926.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e5" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e5" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e5" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e5" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e6" e2="DDI-PubMed.31384926.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e6" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e6" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e6" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e6" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e7" e2="DDI-PubMed.31384926.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e7" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e7" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e7" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e8" e2="DDI-PubMed.31384926.s5.e8" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e8" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e8" e2="DDI-PubMed.31384926.s5.e10" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e9" e2="DDI-PubMed.31384926.s5.e9" /><pair ddi="false" e1="DDI-PubMed.31384926.s5.e9" e2="DDI-PubMed.31384926.s5.e10" /></sentence><sentence text=" Adjusted incidence rate differences between NOAC with or without concurrent AEDs were estimated using Poisson regression models weighted by the inverse probability of treatment" /><sentence text=" Among 104319 patients (age 75" /><sentence text="0Â±10" /><sentence text="3 years; men, 56" /><sentence text="2%), 8546 major bleeding events occurred during 731723 person-quarters with NOAC prescriptions" /><sentence text=" Concurrent AED use was found in 15" /><sentence text="3% of NOAC-treated patients" /><sentence text=" Concurrent use of NOAC with valproic acid, phenytoin, or levetiracetam increased adjusted incidence rates per 1000 person-years of major bleeding more significantly than NOAC alone: 153"><entity charOffset="19-23" id="DDI-PubMed.31384926.s13.e0" text="NOAC" /><entity charOffset="29-42" id="DDI-PubMed.31384926.s13.e1" text="valproic acid" /><entity charOffset="44-53" id="DDI-PubMed.31384926.s13.e2" text="phenytoin" /><entity charOffset="58-71" id="DDI-PubMed.31384926.s13.e3" text="levetiracetam" /><entity charOffset="171-183" id="DDI-PubMed.31384926.s13.e4" text="NOAC" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e0" e2="DDI-PubMed.31384926.s13.e0" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e0" e2="DDI-PubMed.31384926.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e0" e2="DDI-PubMed.31384926.s13.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e0" e2="DDI-PubMed.31384926.s13.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e0" e2="DDI-PubMed.31384926.s13.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e1" e2="DDI-PubMed.31384926.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e1" e2="DDI-PubMed.31384926.s13.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e1" e2="DDI-PubMed.31384926.s13.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e1" e2="DDI-PubMed.31384926.s13.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e2" e2="DDI-PubMed.31384926.s13.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e2" e2="DDI-PubMed.31384926.s13.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e2" e2="DDI-PubMed.31384926.s13.e4" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e3" e2="DDI-PubMed.31384926.s13.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s13.e3" e2="DDI-PubMed.31384926.s13.e4" /></sentence><sentence text="49 for NOAC plus valproic acid vs"><entity charOffset="7-10" id="DDI-PubMed.31384926.s14.e0" text="NOAC" /></sentence><sentence text=" 55" /><sentence text="06 for NOAC alone (difference 98"><entity charOffset="7-10" id="DDI-PubMed.31384926.s16.e0" text="NOAC" /></sentence><sentence text="43, 95% CI 82" /><sentence text="37-114" /><sentence text="49); 135" /><sentence text="83 for NOAC plus phenytoin vs"><entity charOffset="7-10" id="DDI-PubMed.31384926.s20.e0" text="NOAC" /></sentence><sentence text=" 54" /><sentence text="43 for NOAC alone (difference 81"><entity charOffset="7-10" id="DDI-PubMed.31384926.s22.e0" text="NOAC" /></sentence><sentence text="4, 95% CI 60" /><sentence text="14-102" /><sentence text="66); and 132" /><sentence text="96 for NOAC plus levetiracetam vs"><entity charOffset="7-10" id="DDI-PubMed.31384926.s26.e0" text="NOAC" /></sentence><sentence text=" 53" /><sentence text="08 for NOAC alone (difference 79"><entity charOffset="7-10" id="DDI-PubMed.31384926.s28.e0" text="NOAC" /></sentence><sentence text="88, 95% CI 64" /><sentence text="47-95" /><sentence text="30)" /><sentence text="" /><sentence text="For AF patients, the concurrent use of NOACs and valproic acid, phenytoin, or levetiracetam was associated with a higher risk of major bleeding"><entity charOffset="39-44" id="DDI-PubMed.31384926.s33.e0" text="NOACs" /><entity charOffset="49-62" id="DDI-PubMed.31384926.s33.e1" text="valproic acid" /><entity charOffset="64-73" id="DDI-PubMed.31384926.s33.e2" text="phenytoin" /><entity charOffset="78-91" id="DDI-PubMed.31384926.s33.e3" text="levetiracetam" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e0" e2="DDI-PubMed.31384926.s33.e0" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e0" e2="DDI-PubMed.31384926.s33.e1" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e0" e2="DDI-PubMed.31384926.s33.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e0" e2="DDI-PubMed.31384926.s33.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e1" e2="DDI-PubMed.31384926.s33.e1" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e1" e2="DDI-PubMed.31384926.s33.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e1" e2="DDI-PubMed.31384926.s33.e3" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e2" e2="DDI-PubMed.31384926.s33.e2" /><pair ddi="false" e1="DDI-PubMed.31384926.s33.e2" e2="DDI-PubMed.31384926.s33.e3" /></sentence><sentence text="" /></document>